Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis via inducing cell cycle arrest and apoptosis

Table 2 Relationship between ubiquitin-conjugating enzyme E2T expression and clinicopathological parameters by The Cancer Genome Atlas

		Expression of UBE2T		Total	P value
		Low	High
Grade					0.000
	G1/2	137	95	232
	G3/4	47	87	134
Total		184	182	366
T stage					0.001
	T1	108	73	181
	T2	38	56	94
	T3/4	38	55	93
Total		184	184	368
Pathological stage					0.002
	I	101	70	171
	II	36	50	86
	III/IV	37	53	90
Total		174	173	347

UBE2T: Ubiquitin-conjugating enzyme E2T.